Physician profile
Warren Currie Mackie-Jenkins
NPI 1952765323
$64,888.05
in general payments reported to CMS, 2019-2025
15 companies · $23K in 2025
The $23K reported for 2025 was more than what 97% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $506 · 2021: $472 · 2022: $2,910 · 2023: $3,553 · 2024: $35K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $41K · Travel and Lodging: $11K · Food and Beverage: $9,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $40,937.50 |
| Travel and Lodging | $10,947.46 |
| Food and Beverage | $9,114.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $54,037.56 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Abbott Laboratories | $6,103.94 | 2022-2025 | Proclaim, Eterna, Axium |
| Boston Scientific Corporation | $3,909.04 | 2020-2025 | General - Therapies, Wavewriter Alpha Prime 16, General - Pain Management |
| Biotronik Nro, INC. | $263.91 | 2024-2025 | Prospera |
| Mml US, INC. | $197.21 | 2023 | Reactiv8 |
| Nevro Corp. | $115.90 | 2020 | |
| Trice Medical, INC. | $52.58 | 2023 | |
| Medtronic USA, INC. | $40.10 | 2020 | |
| Nalu Medical, INC. | $38.55 | 2023 | Nalu Neurostimulation System |
| Abbvie INC. | $29.05 | 2023 | |
| Arteriocyte Medical Systems, INC. | $27.83 | 2021 | |
| Stryker Corporation | $27.26 | 2020 | |
| Vanda Pharmaceuticals INC. | $19.26 | 2022 | |
| Curonix LLC | $14.69 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $11.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Mackie-Jenkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.